SpA ACR Symposium

Host: Christopher T. Ritchlin, MD, MPH <br> Guest: Atul A. Deodhar, MD, MRCP <br> Guest: Philip J. Mease, MD <br> Guest: Alexis Ogdie, MD, MSCE <br> <p>Can you put the puzzle together in axial spondyloarthritis (axSpA) and axial psoriatic arthritis (axPsA)? </p> <p>Axial involvement is an important feature in patients with SpA and PsA, and this manifestation has various similarities and differences between both diseases.^1,2 Recognizing and assessing the unique presentation of axPsA and axSpA is critical to improve the outcomes in our patients.</p> <p>Listen in to a discussion panel moderated by Christopher T. Ritchlin, MD with Atul Deodhar, MD, Philip Mease, MD, and Alexis Ogdie-Beatty, MD, as they discuss current diagnostic challenges and new insights on the assessment of axial features.</p> <p>This presentation is sponsored by Novartis Medical Affairs and all speakers have been compensated for their time.</p> <p><strong>References</strong></p> <ol> <li>Feld J, Chandran V, Haroon N, Inman R, Gladman D. Axial disease in psoriatic arthritis and ankylosing spondylitis: A critical comparison. <em>Nat Rev Rheumatol.</em> 2018;14(6):363-371. doi:10.1038/s41584-018-0006-8</li> <li>Helliwell PS. Axial disease in psoriatic arthritis.<em> Rheumatology. </em>2019:1-3. doi:10.1093/rheumatology/kez629</li> </ol> <p style="text-align: right;">3/21 M-XAT-1399851​</p> <p> </p>